NLRP3 and type 2 diabetes mellitus: Earlier studies have demonstrated activation of the NLRP3 inflammasome and increased expression of IL-1β in both type 1 (ref. 39) and type 2 (refs 40, 41) diabetes (T1D and T2D), but until now their relevance in the pathogenesis of diabetic heart disease has been unknown.